Green Thumb Industries Inc. (GTBIF) Financials
GTBIF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 2.8 billion | 954.6 million |
| March 31, 2026 | 2.8 billion | 934.6 million |
| Dec. 31, 2025 | 2.8 billion | 879.4 million |
| Sept. 30, 2025 | 2.6 billion | 804.3 million |
GTBIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 8.8 million | 10.6 million |
| March 31, 2026 | 56.9 million | 10.5 million |
| Dec. 31, 2025 | 75.5 million | 11.0 million |
| Sept. 30, 2025 | 56.6 million | 11.7 million |
GTBIF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 4.9 million |
| March 31, 2026 | 15.4 million |
| Dec. 31, 2025 | 84.8 million |
| Sept. 30, 2025 | 21.8 million |
GTBIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 283.6 million | 259.0 million | 255.1 million |
| March 31, 2026 | 346.2 million | 266.3 million | 272.4 million |
| Dec. 31, 2025 | 274.3 million | 226.0 million | 273.0 million |
| Sept. 30, 2025 | 235.4 million | 484.1 million | 270.6 million |
GTBIF Shares Outstanding
GTBIF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 20.2 million | - | 117.9 million | - |
| March 31, 2026 | 18.9 million | - | 102.9 million | - |
| Dec. 31, 2025 | 14.7 million | - | 122.3 million | - |
| Sept. 30, 2025 | 17.5 million | - | 107.3 million | - |
GTBIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 306.7 million | 168.8 million |
| March 31, 2026 | 300.2 million | 156.5 million |
| Dec. 31, 2025 | 311.1 million | 169.8 million |
| Sept. 30, 2025 | 291.4 million | 147.3 million |
GTBIF Revenue by Segment
Graph available only for paid members. Upgrade to see it.
GTBIF
Price: $6.63
52 week price:
Payout Ratio Range:
Earnings Per Share: 0.17 USD
P/E Ratio: 38.24
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 658300
Market Capitalization: 1.4 billion